AIR insulin capsules of different dose strengths may be combined to yield equivalent pharmacokinetics and glucodynamics

Diabetes Technology and Therapeutics

Volumn 11, Issue SUPPL. 2, 2009, Pages

  De La Peña, Amparo ^a   Seger, Mary ^a   Rave, Klaus ^b   Heinemann, Lutz ^b   Silverman, Bernard ^c   Muchmore, Douglas B ^d  

^a ELI LILLY AND COMPANY   (United States)

^b Profil Institut fur Stoffwechselforschung GmbH   (Germany)

^c ALKERMES INC   (United States)

^d Halozyme Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AIR INHALED INSULIN; HEMOGLOBIN A1C; INSULIN; INSULIN GLARGINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG WITHDRAWAL; DYSPNEA; FEMALE; GLYCEMIC CONTROL; HEADACHE; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, INHALATION; AREA UNDER CURVE; BLOOD GLUCOSE; FEMALE; FORCED EXPIRATORY VOLUME; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; KINETICS; MALE; RANDOM ALLOCATION; REFERENCE VALUES; VITAL CAPACITY;

EID: 70349445241     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2009.0057     Document Type: Article

References (15)

1. Rave KM, Nosek L, de la Peñ a A, Seger M, Ernest CS, Heinemann L, Batycky RP, Muchmore DB: Dose response of inhaled dry-powder insulin and dose equivalence to subcutaneous insulin lispro. Diabetes Care 2005;28:2400-2405
2. Byron PR, Patton JS: Drug delivery via the respiratory tract. J Aerosol Med 1994;7:49-75
3. Cefalu WT, Skyler JS, Kourides IA, Landschulz WH, Balagtas CC, Cheng S, Gelfand RA: Inhaled human insulin treatment in patients with type 2 diabetes mellitus. Ann Intern Med 2001;134:203-207
4. Skyler JS, Weinstock RS, Raskin P, Yale JF, Barrett E, Gerich JE, Gerstein HC: Use of inhaled insulin in a basal=bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial. Diabetes Care 2005;28:1630-1635
5. Weiss SR, Cheng SL, Kourides IA, Gelfand RA, Landschulz WH: Inhaled insulin provides improved glycemic control in patients with type 2 diabetes mellitus inadequately controlled with oral agents: a randomized controlled trial. Arch Intern Med 2003;163:2277-2282
6. Garg S, Rosenstock J, Silverman BL, Sun B, Konkoy CS, de la Peñ a A, Muchmore DB: Efficacy and safety of preprandial human insulin inhalation powder versus injectable insulin in patients with type 1 diabetes. Diabetologia 2006;49:891-899
7. Gern JE, Stone CK, Nakano M, Muchmore DB, de la Peña A, Park S, Suri A, Tibaldi F, Soon D, Busse WW: Effect of upper respiratory tract infection on AIR inhaled insulin pharmacokinetics and glucodynamics in healthy subjects. Clin Pharmacol Ther 2008;83:307-311
8. Pan AX, de la Peñ a A, Yeo KP, Chan C, Loh MT, Wise SD, Silverman BL, Muchmore DB: Effects of smoking cessation, acute re-exposure and nicotine replacement in smokers on AIR inhaled insulin pharmacokinetics and glucodynamics. Br J Clin Pharmacol 2008;65:480-487
9. Rave K, de la Peñ a A, Tibaldi FS, Zhang L, Silverman B, Hausmann M, Heinemann L, Muchmore DB: AIR inhaled insulin in subjects with chronic obstructive pulmonary disease: pharmacokinetics, glucodynamics, safety, and tolerability. Diabetes Care 2007;30:1777-1782
10. Rosenstock J, Nakano M, Silverman BL, Sun B, de la Peña A, Suri A, Muchmore DB: Comparison of standard (selfdirected) versus intensive patient training for the human insulin inhalation powder (HIIP) delivery system in patients with type 2 diabetes: efficacy, safety, and training measures. Diabetes Technol Ther 2007;9:80-88
11. Wolzt M, de la Peñ a A, Berclaz PY, Tibaldi FS, Gates JR, Muchmore DB: AIR inhaled insulin versus subcutaneous insulin: pharmacokinetics, glucodynamics, and pulmonary function in asthma. Diabetes Care 2008;31:735-740
12. Muchmore DB, Silverman B, de la Peñ a A, Tobian J: The AIR inhaled insulin system: system components and pharmacokinetic=glucodynamic data. Diabetes Technol Ther 2007;9(Suppl 1):S41-S47
13. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-E223
14. Smith BP, Vandenhende FR, DeSante KA, Farid NA, Welch PA, Callaghan JT, Forgue ST: Confidence interval criteria for assessment of dose proportionality. Pharm Res 2000;17: 1278-1283
15. Exubera [package insert]. New York: Pfizer, 2008